WASHINGTON, D.C., March 25, 2026 – This week, The ERISA Industry Committee (ERIC) will mark its 50th anniversary during its annual spring conference in Washington, DC. While the conference will bring together large employer benefits, compensation, and legal professionals, along with federal policymakers for discussions on employee benefits, health care, and retirement policy, the event will also serve to commemorate a significant milestone in the organization’s history.
Miscellaneous Archives:
ERIC: RESTORE Act Will Drive Up Costs Without Improving Patient Care
Washington, D.C., March 19, 2026 – On Wednesday, the House Ways and Means Health Subcommittee held a hearing examining advances in kidney care, Medicare payment reforms for End Stage Renal Disease (ESRD), and the importance of health care solutions tailored to the needs of patients, including facilitating transplantation and home dialysis.
Employers Oppose Dialysis Policies that Increase Costs on Patients
WASHINGTON, DC – The Partnership for Employer-Sponsored Coverage (P4ESC) applauds Congress for raising the concerns of patients struggling with end-stage renal disease (ESRD) and opposes policies that would increase costs for these patients and the employers who provide their dialysis coverage such as the Restore Protections for Dialysis Patients Act.
ERIC Applauds Action on the ERISA Litigation Reform Act
Washington, D.C., March 17, 2026 – Today, Andy Banducci, Senior Vice President of Retirement and Compensation Policy at The ERISA Industry Committee (ERIC), issued the statement below following action by the U.S. House Education and Workforce Committee to advance the ERISA Litigation Reform Act (H.R. 6084).
Employer Coalition Applauds Bill to Boost Competition and Improve Affordability
Washington, D.C., March 16, 2026 – The ERISA Industry Committee (ERIC), along with a coalition of allies in the employer community, wrote to lawmakers today praising the introduction of the bipartisan “Healthy Competition for Better Care Act.”
ERIC Applauds FDA Action on Biosimilars to Reduce Drug Costs
Washington, D.C., March 10, 2026 – The ERISA Industry Committee (ERIC) issued the following statement today regarding the Trump Administration’s announcement to make biosimilar development faster and more affordable. The statement can be attributed to ERIC President and CEO, James Gelfand.
As Arbitration Drive Up Healthcare Costs, Diverse Stakeholders Call for Stronger Federal Oversight
The ERISA Industry Committee (ERIC) along with more than 60 groups representing employers, labor, patients, and consumers today urged The U.S. Departments of Labor, Health and Human Services, and Treasury (the Tri-Departments) to take immediate action to address severe and negative consequences of the Independent Dispute Resolution (IDR) process under the No Surprises Act (NSA). While the NSA was designed to prevent surprise medical bills and lower health care costs, abuse of the IDR process is raising costs for patients, plan sponsors, health plans, and the broader health care system.
ERIC Offers Recommendations to Improve Health Care Price Transparency
The ERISA Industry Committee (ERIC) today submitted recommendations in response to a proposal by The U.S. Departments of Labor, Health and Human Services, and Treasury (the Tri-Departments) amending the Transparency in Coverage (“TiC”) regulations, which require public disclosure of health care prices paid by insurance companies and self-insured employer-sponsored health plans. The proposed rules aim to standardize and improve the accuracy and accessibility of TiC pricing disclosures, while reducing the size, number, and duplication of data in TiC Machine-Readable Files (MRFs).
ERIC Submits Recommendations to Treasury and IRS to Maximize Workability of Trump Accounts
Washington, D.C., February 20, 2026– The ERISA Industry Committee (ERIC) today submitted comments to the Department of the Treasury and the Internal Revenue Service (IRS) on the guidance and request for information related to section 530A establishing Trump accounts. The provision, which was included in the One Big Beautiful Bill Act, establishes new tax-advantaged investment accounts for U.S. children under the age of 18.
P4ESC Members Testify Before Congress on Health Care Affordability
WASHINGTON, DC – February 11, 2026 – The Partnership for Employer-Sponsored Coverage (P4ESC) members today are bringing employer-focused solutions to Capitol Hill, with James Gelfand, President and CEO of The ERISA Industry Committee (ERIC) and Dr. Lee Gross, Founder of Epiphany Health Direct Primary Care and member of National Federation of Independent Business (NFIB), testifying in hearings centered on the cost and access pressures facing patients and employers.